Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a neuromodulation company incorporated as a Delaware corporation in 1987, engaged in the design, development, sales and marketing of implantable medical devices that provide a unique therapy, vagus nerve stimulation therapy (VNS Therapy™), for the treatment of refractory epilepsy and treatment-resistant depression. Our proprietary VNS Therapy System includes the following: — A generator to provide the appropriate stimulation to the vagus nerve; — A lead that connects the generator to the vagus nerve; — Associated equipment to assist with implantation surgery; — Equipment to assist with setting the stimulation parameters particular to the patient; — Appropriate instruction manuals; and — Magnets to suspend or induce stimulation manually. ... More ...
Analyst Info |
|
| Annual EPS Est: | $1.27 |
| Quarterly EPS Est: | 0.42 |
| PEG Ratio: | 1.51 |
|
Mean Recommendation: View Summary / View All |
1.7 |
Data is provided by Zacks Investment Research

